XTSE
IVQ
Market cap129mUSD
Oct 07, Last price
0.14USD
1D
3.70%
1Q
12.00%
IPO
-98.44%
Name
Invesque Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Invesque Inc. functions as a real estate investment firm specializing in the healthcare industry. Its comprehensive property portfolio spans a variety of asset classes, including independent living, assisted living, memory care, skilled nursing, transitional care, and medical office facilities. As of March 11, 2022, the company oversaw a collection of 88 properties. Specifically, its U.S. holdings consisted of 60 assisted living and memory care residences, 12 skilled nursing homes, 10 transitional care centers, and 4 medical office buildings. In Canada, the company maintained 15 properties, which included 11 medical office structures and 4 seniors housing and care establishments. Additionally, Invesque engages in investments involving owner-occupied seniors housing properties, encompassing both real estate ownership and management services. The organization, originally incorporated in 2007 and headquartered in Toronto, Canada, changed its name from Mainstreet Health Investments Inc. to Invesque Inc. in January 2018.
Key people
Scott White
Chairman of the Board · since 2024
Adlai Chester
Chief Executive Officer, Director · since 2024
Quinn Haselhorst
Chief Financial Officer · since 2024
Gail Steinel
Lead Independent Director · since 2024
Bradley Benbow
Independent Director · since 2022
Shaun Hawkins
Independent Director · since 2016
Legal address
700 West Georgia Street
25th Floor
Vancouver, BC V7Y 1B3
CA
25th Floor
Vancouver, BC V7Y 1B3
CA
Headquarters
333 Bay Street
Suite 3400
Toronto, ON M5H 2S7
CA
Suite 3400
Toronto, ON M5H 2S7
CA
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||